221 related articles for article (PubMed ID: 31439023)
1. Enhancement of tripartite synapses as a potential therapeutic strategy for Alzheimer's disease: a preclinical study in rTg4510 mice.
Foster JB; Lashley R; Zhao F; Wang X; Kung N; Askwith CC; Lin L; Shultis MW; Hodgetts KJ; Lin CG
Alzheimers Res Ther; 2019 Aug; 11(1):75. PubMed ID: 31439023
[TBL] [Abstract][Full Text] [Related]
2. Restored glial glutamate transporter EAAT2 function as a potential therapeutic approach for Alzheimer's disease.
Takahashi K; Kong Q; Lin Y; Stouffer N; Schulte DA; Lai L; Liu Q; Chang LC; Dominguez S; Xing X; Cuny GD; Hodgetts KJ; Glicksman MA; Lin CL
J Exp Med; 2015 Mar; 212(3):319-32. PubMed ID: 25711212
[TBL] [Abstract][Full Text] [Related]
3. Pyridazine-derivatives Enhance Structural and Functional Plasticity of Tripartite Synapse Via Activation of Local Translation in Astrocytic Processes.
Foster JB; Zhao F; Wang X; Xu Z; Lin K; Askwith CC; Hodgetts KJ; Lin CG
Neuroscience; 2018 Sep; 388():224-238. PubMed ID: 30056115
[TBL] [Abstract][Full Text] [Related]
4. Rutin prevents tau pathology and neuroinflammation in a mouse model of Alzheimer's disease.
Sun XY; Li LJ; Dong QX; Zhu J; Huang YR; Hou SJ; Yu XL; Liu RT
J Neuroinflammation; 2021 Jun; 18(1):131. PubMed ID: 34116706
[TBL] [Abstract][Full Text] [Related]
5. Selective Disruption of Inhibitory Synapses Leading to Neuronal Hyperexcitability at an Early Stage of Tau Pathogenesis in a Mouse Model.
Shimojo M; Takuwa H; Takado Y; Tokunaga M; Tsukamoto S; Minatohara K; Ono M; Seki C; Maeda J; Urushihata T; Minamihisamatsu T; Aoki I; Kawamura K; Zhang MR; Suhara T; Sahara N; Higuchi M
J Neurosci; 2020 Apr; 40(17):3491-3501. PubMed ID: 32265258
[TBL] [Abstract][Full Text] [Related]
6. Small-molecule activator of glutamate transporter EAAT2 translation provides neuroprotection.
Kong Q; Chang LC; Takahashi K; Liu Q; Schulte DA; Lai L; Ibabao B; Lin Y; Stouffer N; Das Mukhopadhyay C; Xing X; Seyb KI; Cuny GD; Glicksman MA; Lin CL
J Clin Invest; 2014 Mar; 124(3):1255-67. PubMed ID: 24569372
[TBL] [Abstract][Full Text] [Related]
7. TAPPing into the potential of inducible tau/APP transgenic mice.
Xu G; Ulm BS; Howard J; Fromholt SE; Lu Q; Lee BB; Walker A; Borchelt DR; Lewis J
Neuropathol Appl Neurobiol; 2022 Apr; 48(3):e12791. PubMed ID: 35067965
[TBL] [Abstract][Full Text] [Related]
8. Synaptic alterations in the rTg4510 mouse model of tauopathy.
Kopeikina KJ; Polydoro M; Tai HC; Yaeger E; Carlson GA; Pitstick R; Hyman BT; Spires-Jones TL
J Comp Neurol; 2013 Apr; 521(6):1334-53. PubMed ID: 23047530
[TBL] [Abstract][Full Text] [Related]
9. The flavonoid baicalein rescues synaptic plasticity and memory deficits in a mouse model of Alzheimer's disease.
Gu XH; Xu LJ; Liu ZQ; Wei B; Yang YJ; Xu GG; Yin XP; Wang W
Behav Brain Res; 2016 Sep; 311():309-321. PubMed ID: 27233830
[TBL] [Abstract][Full Text] [Related]
10. Genome-wide RNAseq study of the molecular mechanisms underlying microglia activation in response to pathological tau perturbation in the rTg4510 tau transgenic animal model.
Wang H; Li Y; Ryder JW; Hole JT; Ebert PJ; Airey DC; Qian HR; Logsdon B; Fisher A; Ahmed Z; Murray TK; Cavallini A; Bose S; Eastwood BJ; Collier DA; Dage JL; Miller BB; Merchant KM; O'Neill MJ; Demattos RB
Mol Neurodegener; 2018 Dec; 13(1):65. PubMed ID: 30558641
[TBL] [Abstract][Full Text] [Related]
11. Early depletion of CA1 neurons and late neurodegeneration in a mouse tauopathy model.
Helboe L; Egebjerg J; Barkholt P; Volbracht C
Brain Res; 2017 Jun; 1665():22-35. PubMed ID: 28411086
[TBL] [Abstract][Full Text] [Related]
12. Impact of a pyridazine derivative on tripartite synapse ultrastructure in hippocampus: a three-dimensional analysis.
Xu Z; Foster JB; Lashley R; Wang X; Benson E; Kidd G; Lin CG
Front Cell Neurosci; 2023; 17():1229731. PubMed ID: 37671169
[TBL] [Abstract][Full Text] [Related]
13. Selenomethionine ameliorates cognitive decline, reduces tau hyperphosphorylation, and reverses synaptic deficit in the triple transgenic mouse model of Alzheimer's disease.
Song G; Zhang Z; Wen L; Chen C; Shi Q; Zhang Y; Ni J; Liu Q
J Alzheimers Dis; 2014; 41(1):85-99. PubMed ID: 24577479
[TBL] [Abstract][Full Text] [Related]
14. Disease modifying effect of chronic oral treatment with a neurotrophic peptidergic compound in a triple transgenic mouse model of Alzheimer's disease.
Kazim SF; Blanchard J; Dai CL; Tung YC; LaFerla FM; Iqbal IG; Iqbal K
Neurobiol Dis; 2014 Nov; 71():110-30. PubMed ID: 25046994
[TBL] [Abstract][Full Text] [Related]
15. Sleep Disruption Precedes Forebrain Synaptic Tau Burden and Contributes to Cognitive Decline in a Sex-Dependent Manner in the P301S Tau Transgenic Mouse Model.
Martin SC; Joyce KK; Lord JS; Harper KM; Nikolova VD; Cohen TJ; Moy SS; Diering GH
eNeuro; 2024 Jun; 11(6):. PubMed ID: 38858068
[TBL] [Abstract][Full Text] [Related]
16. The mTOR Inhibitor Rapamycin Mitigates Perforant Pathway Neurodegeneration and Synapse Loss in a Mouse Model of Early-Stage Alzheimer-Type Tauopathy.
Siman R; Cocca R; Dong Y
PLoS One; 2015; 10(11):e0142340. PubMed ID: 26540269
[TBL] [Abstract][Full Text] [Related]
17. In vivo axonal transport deficits in a mouse model of fronto-temporal dementia.
Majid T; Ali YO; Venkitaramani DV; Jang MK; Lu HC; Pautler RG
Neuroimage Clin; 2014; 4():711-7. PubMed ID: 24936422
[TBL] [Abstract][Full Text] [Related]
18. Cornel Iridoid Glycoside Suppresses Tau Hyperphosphorylation and Aggregation in a Mouse Model of Tauopathy through Increasing Activity of PP2A.
Ma D; Luo Y; Huang R; Zhao Z; Wang Q; Li L; Zhang L
Curr Alzheimer Res; 2019; 16(14):1316-1331. PubMed ID: 31902362
[TBL] [Abstract][Full Text] [Related]
19. Rifampicin is a candidate preventive medicine against amyloid-β and tau oligomers.
Umeda T; Ono K; Sakai A; Yamashita M; Mizuguchi M; Klein WL; Yamada M; Mori H; Tomiyama T
Brain; 2016 May; 139(Pt 5):1568-86. PubMed ID: 27020329
[TBL] [Abstract][Full Text] [Related]
20. Tau reduction in the presence of amyloid-β prevents tau pathology and neuronal death in vivo.
DeVos SL; Corjuc BT; Commins C; Dujardin S; Bannon RN; Corjuc D; Moore BD; Bennett RE; Jorfi M; Gonzales JA; Dooley PM; Roe AD; Pitstick R; Irimia D; Frosch MP; Carlson GA; Hyman BT
Brain; 2018 Jul; 141(7):2194-2212. PubMed ID: 29733334
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
